Inventors with similar research interests:
Location History:
- Allston, MA (US) (1994 - 2001)
- Framingham, MA (US) (1995 - 2003)
- Belmont, MA (US) (2000 - 2013)
- Bedford, MA (US) (2013 - 2023)
Company Filing History:
46 out of 141 
13 out of 17 
9 out of 119 
Years Active: 1994-2023
Title: Xiong Cai: Innovative Collaborations Bringing Ideas to Life
Introduction:
Xiong Cai, based in Bedford, MA (US), is a prolific inventor known for his remarkable work in the field of phosphoinositide 3-kinase (PI3K) inhibitors. With an extensive portfolio of 73 patents, his groundbreaking research has led to the development of compounds with immense potential in the treatment of various diseases, including cancer and histone deacetylase (HDAC) related disorders. Let's delve into Xiong Cai's latest patents, career highlights, and noteworthy collaborations.
Latest Patents:
Xiong Cai's recent patents demonstrate his focus on PI3K inhibitors with a zinc binding moiety. The first patent, titled "Phosphoinositide 3-kinase inhibitor with a zinc binding moiety," revolves around a compound (Formula I) and its pharmaceutical compositions. These compounds offer immense therapeutic benefits in the treatment of PI3K-related diseases and disorders, such as cancer. Additionally, the patent includes the treatment of HDAC-related diseases and those involving both HDAC and PI3K.
The second patent, "Phosphoinositide 3-kinase inhibitors with a zinc binding moiety," explores the use of deazapurines, thienopyrimidines, and furopyrimidines with zinc-binding moiety based derivatives. Similar to the first patent, this invention targets PI3K-related diseases and disorders, highlighting the treatment of cancer and conditions related to HDAC and PI3K.
Career Highlights:
Xiong Cai's career is marked by a series of remarkable achievements. His relentless pursuit of innovation and dedication to scientific research have earned him recognition in the field of PI3K inhibitors. With an impressive portfolio of 73 patents, Cai has consistently pushed the boundaries of medical advancements and played a pivotal role in improving patient outcomes.
Collaborations:
Xiong Cai's success is attributable not only to his individual brilliance but also to his fruitful collaborations with various organizations and individuals. Notably, he has worked with reputable companies such as Curis, Inc. and Cytomed, Inc. These collaborations have provided him with the platform and resources necessary to further develop and commercialize his inventions.
Furthermore, Cai has collaborated with esteemed colleagues, including Changgeng Qian and Haixiao Zhai. Their combined expertise and shared passion for advancing medical treatments have resulted in significant breakthroughs in the development of novel PI3K inhibitors.
Conclusion:
Xiong Cai's remarkable journey as an inventor and scientist has led to the creation of several groundbreaking patented inventions in the field of PI3K inhibitors. His dedication to improving patient outcomes and collaborative efforts with esteemed organizations and colleagues have solidified his position as a prominent figure in the field. The patents discussed here represent just a fraction of his impressive portfolio, highlighting his unwavering commitment to innovation and the potential impact of his contributions on the field of medical research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.